Skip to main content
. 2021 Apr 21;9(5):445. doi: 10.3390/biomedicines9050445

Figure 4.

Figure 4

Correlation between anti-FXa bioassays and the LC-MS/MS (edoxaban + M4) method on 144 edoxaban plasma samples from healthy volunteers. (A) BIOPHEN™ Heparin LRT and (B) BIOPHEN™ direct factor Xa inhibitor (DiXaI) (data not published).